Marvels in Medicine: Dr. Gradishar on the Personal Pursuit of Precision Medicine in Breast Cancer

June 11, 2020

Partner | Cancer Centers | <b>Robert H. Lurie Comprehensive Cancer Center of Northwestern University Northwestern Medicine</b>

In our exclusive interview, Dr. Gradishar shares the path that led him to specialize in the field of breast cancer, collective experiences that have inspired him throughout his career, and his hope for the continued transition from “shotgun medicine” to precision medicine in the field.

Welcome to a very special edition of OncLive On Air! I’m your host today, Caroline Seymour.

OncLive On Air is a podcast from OncLive, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, OncLive covers every angle of oncology practice, from new technology to treatment advances to important regulatory decisions.

Today, we had the pleasure of speaking with William J. Gradishar, MD, chief of hematology and oncology in the Department of Medicine, Betsy Bramsen Professorship of Breast Oncology, and professor of medicine in Hematology and Oncology at Northwestern University's Feinberg School of Medicine. Dr. Gradishar’s research is focused on the development of novel therapeutics in breast cancer.

He has co-authored over 300 publications with the goal of bringing precision medicine to the forefront of treatment for patients with this disease.

In our exclusive interview, Dr. Gradishar shared the path that led him to specialize in the field of breast cancer, collective experiences that have inspired him throughout his career, and his hope for the continued transition from “shotgun medicine” to precision medicine in the field.